Table 3.

Clinical data and cell division abnormalities scored in tissue sections

CaseAge (y)/sexTumor diameter (cm)HistologyStageTime to relapse (mo)Sample topographyFollow-up time (y)Status at last follow-upAB (%)MM (%)
P13/M5IIINephrectomy10NED00
P26/F12IIIINephrectomy9NED00
P30.4/F9IINephrectomy8NED00
3Lung**
P42/M15IIINephrectomy1.5DOD41
3Regional61
9Regional101
P515/F10H (B)IINephrectomy1DOD141
12Lung92
P66/F12IINephrectomy1.5DOD00
12Regional--
21Regional00
30Regional30
P76/M13H (B)IVNephrectomy1DOD1110
5Lung, bone
P86/M7IIINephrectomy5.5NED00
P94/F11IINephrectomy4NED00
P104/F4IIINephrectomy2NED00
P112/F10IINephrectomy1.5NED31
P126/M14IIINephrectomy0.75NED00
P134/M7IIINephrectomy1.5NED00
P141/F12H (B)INephrectomy0.5NED00
P154/M15H (B)VNephrectomy1DOD81
4Lung114
P160.6/M15H (A)IIINephrectomy0.5DOD82
4Regional, lung, brain
P172/M9IINephrectomy1.5NED00
P184/M7IIINephrectomy2.5NED00
8Regional, lung00
P194/M8IIIINephrectomy10NED00
P202/F2IINephrectomy8NED00
P212/F7; 3IVNephrectomy9NED00
P223/M7IIVNephrectomy9NED00
P231/F8II6Nephrectomy9NED00
Contralateral kidney00
P241/F12; 4IVNephrectomy8.5NED00
P256/M12H (A)IIINephrectomy8DOC105
P267/F10IIINephrectomy8NED00
P2718/F5H (B)IVNephrectomy0.1DOD31
P282/M5IIVNephrectomy10NED00
P2910/M14IIINephrectomy10NED00
P301/M4IINephrectomy10NED00
84Contralateral kidney
P318/M7IINephrectomy10NED00
P329/M5IIIINephrectomy9NED00
P334/F8IIINephrectomy12NED00
P343/F13IINephrectomy13.5NED00
P353/F4IINephrectomy5NED00
P362/F14IINephrectomy13NED00
P371/M11IINephrectomy14NED00
P383/F11IIINephrectomy12NED00
P392/F9IINephrectomy11.5NED00
P401/M9IINephrectomy10.5NED00
P410.5/M7IINephrectomy10NED00
  • Abbreviations: (A), anaplastic subtype; (B), blastemal subtype; NED, no evidence of disease; DOD, dead of disease; DOC, dead of complications; AB, frequency of anaphase cells with bridges; MM, frequency of multipolar mitotic cells.

  • * Not determined.